Add like
Add dislike
Add to saved papers

In Vivo Evaluation of Galla chinensis Solution in the Topical Treatment of Dermatophytosis.

Aim: Dermatophytosis is one of the main fungal diseases in humans and animals all over the world. Galla chinensis , a traditional medicine, has various pharmacological effects. The goal of this study was to evaluate the treatment effect of Galla chinensis solution (GCS) on dermatophytosis-infected dogs ( Microsporum canis , Microsporum gypseum , and Trichophyton mentagrophytes , resp.).

Methods: The treatment effects of GCS were evaluated by mycological cure rates and clinical score comprised of three indices, including inflammation, hair loss, and lesion scale.

Results: The results showed that, in the three models of dermatophytosis, GCS significantly ( P < 0.05) improved skin lesions and fungal eradication. GCS (10% and 5%) had higher efficacy compared to the positive control (Tujingpi Tincture). The fungal eradication efficacy exceeds 85% after treatment with GCS (10%, 5%, and 2.5%) on day 14.

Conclusion: The GCS has antidermatophytosis effect in dogs, which may be a candidate drug for the treatment of dermatophytosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app